← Human Trials & Peer-Reviewed Studies
The effect of three years of vitamin D supplementation on erectile dysfunction: Results from the randomized placebo-controlled D-Health Trial.
Plain-language guide to PMID 38479897 (2024): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 38479897
- Journal
- Clinical nutrition ESPEN
- Year
- 2024
- Study type
- Randomized Controlled Trial
- Authors
- Duarte Romero B et al. (15 authors)
- DOI
- 10.1016/j.clnesp.2024.01.011
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
However, this association may be due to uncontrolled confounding, and there is a paucity of evidence from interventional studies.
The researchers aimed to examine the effect of vitamin D supplementation on the prevalence of erectile dysfunction, in an exploratory analysis using data from a large randomized controlled trial.
The researchers used log-binomial regression to examine the effect of vitamin D on the prevalence of erectile dysfunction overall, and within sub-groups.
Who Took Part
By PubMed's age tags, the people studied were middle-aged adults, older adults and people over 80, men only.
Blood samples were collected annually from randomly selected participants (total N = 3943).
How the Study Was Run
In design terms this was a randomized and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
The researchers assessed erectile dysfunction at the end of the third year of follow-up.
What Was Measured
Topics PubMed links to this paper include Australasian People, Australia, Calcifediol, Dietary Supplements, Erectile Dysfunction, Vitamin D and Vitamins.
The authors tagged it with the keywords Impotence.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2024 (Clinical nutrition ESPEN), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.